StockWatch
·
MACFOS LTD · QQ2 FY-2027 · THE CALL

H1 growth masks Q2 decline; inventory buildup and margin pressure persist

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsROBUMacfos Ltd12 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade C

H1 met claimed 41% growth; Q2 missed YoY by 22.7%. Prior guidance vague, new guidance withdrawn.

Short-term outlook

Neutral

next 1–2 quarters

Long-term outlook

Cautiously Optimistic

multi-year

H1 growth of 41% revenue is offset by Q2's -22.7% YoY decline, signaling demand weakness in the back half. Inventory has doubled to 120+ days, refund costs spiked 10-fold, and gross margins remain flat despite Robu 2.0 push. Long-term electronics tailwind is credible, but near-term execution is faltering and management is unwilling to commit to specific guidance.

₹181.96 Cr

Revenue · +41% YoY

₹13.18 Cr

Reported PAT · +31% YoY

Flat

Margins · vs guidance: Overstated

Did the claims hold up?

Management's claims vs. the numbers

41% H1 revenue growth; 34% EBITDA, 31% PAT growth

OVERSTATED

Q2 alone -22.7% revenue YoY, -27.6% PAT YoY; H1 growth backloaded to Q1

Gross margins stable, focus on Robu 2.0 margin uplift

MISS

Gross margin in same line, no improvement. Robu 2.0 <2% revenue, immaterial

Inventory expansion is strategic to serve growing demand

OVERSTATED

Days doubled 60–65 → 120+ due to import costs, financing constraints, not demand

Continued strength and underlying business resilience

MISS

Q2 revenue down 22.7%, PAT down 27.6% YoY; refund backlog INR35–40L spiked to INR1.7Cr

Earnings quality

What changed since the last call

Deltas vs. the prior call

Growth guidance withdrawn, numbers now avoided

Downgrade

FY-2026 calls promised 'strong growth'; management now refuses to quantify. MD: 'We have decided not to go in that direction, just to keep on putting some numbers.' Signals reduced conviction.

Inventory build-out accelerated; Q1 strong masked Q2 miss

Downgrade

H1 +41% growth; Q2 -22.7% YoY. Inventory 120+ days vs. prior 60–65, driven by sea freight economics and financing burden, not demand strength.

Refund/return costs surged; operational backlog disclosed

Downgrade

INR1.7Cr return & replacement this quarter (10x prior), vs. INR35–40L 'strategic' backlog. MD expects normalization by Q3 but flagged fulfillment friction.

The Q&A

Analysts pressed on inventory days, gross margins, Robu 2.0 revenue, and cash flow. Management deflected on specifics (won't share mix, won't commit growth numbers), justified inventory with supply-chain costs, and acknowledged margin pressure but claimed it will normalize. Tone defensive; held up poorly to scrutiny on near-term metrics.

The exchanges that mattered

Robu 2.0 traction & revenue contribution — Praneeth, SJ Investments

Dodged

~310 SKUs in SmartLex, 12–15 in drones, multiple in Pro-Range, EasyMech. <2% revenue. Focusing on market testing, not sharing numbers yet; will disclose when product-market fit proven.

Inventory days explosion — Swaraj Mehta, Perpetual Capital Advisors

Partial

Inventory days = function of import costs, sea freight, strategic accumulation. Won't share internal targets (public calls, we put out numbers, competitors watch). Expects 120 to stabilize or improve next year.

Gross margin outlook — Swaraj Mehta, Perpetual Capital Advisors

Partial

Gross margin in same line, no recent change. Want higher margins, but Robu 2.0 still early. Will keep trying different products to improve.

Growth sustainability & capex — Praneeth, SJ Investments

Partial

Yes, we expect 30–40% growth next 4–5 years. Growing with existing bank financing, no plans for equity raise. Partners are happy to support cash flows.

Competitor impact & market share — Praneeth, SJ Investments

Partial

Millennium's model is different (high-volume, manufacturers). RayQ is a distributor (different business). Won't impact Robu's direct model significantly.

Return & replacement cost drivers — Jojo Shaju, Tirthban Capital

Answered

Nothing to do with Robu 2.0. Operational backlog: INR35–40L in unfulfilled refunds. Sea freight backlog, not quality. Will normalize next quarter when backlog clears.

Revenue mix: corporate vs. hobby/startup — Jojo Shaju, Tirthban Capital

Dodged

Not sharing breakdown. Corporate segment growing, but we also need starter customers who convert over time. Long-term, more corporate revenue. But small & medium orders both important.

PAT margin sustainability — Praneeth, SJ Investments

Answered

Targeting 7–8% PAT margin. Won't go below that aggregate. Average order value for corporate is higher, less overhead; so corporate growth actually helps maintain margins.

Supplier payment terms & working capital — Praneeth, SJ Investments

Answered

Yes. Supplier credit terms increasing. Bank relationships strong. Will negotiate better rates as volumes grow. Cost of funds improving gradually.

Robu 2.0 IP moat & competitive sustainability — Rohit, ithoughtPMS

Partial

Robu 2.0 is in-house development. Market is expanding (3D printers, drones, wireless, health trackers didn't exist 5–10 years ago). Creating own market, not just taking share.

Migration to mainboard; equity dilution — Rohit, ithoughtPMS

Answered

No plans. Equity is costliest money. Prefer to grow via debt and internal cash flows. Only equity as last resort.

Guidance

Forward guidance and management's confidence

30–40% growth next 4–5 years; no annual targets

Low

Management explicitly declined to quantify. MD: 'We have decided not to go in that direction.' Vague timeline, no milestones.

7–8% PAT margin floor; gross margin stable

Medium

Currently at 7.4% PAT (in range). Won't go below stated floor. Gross margin unlikely to improve near-term (Robu 2.0 immaterial).

Risks the call surfaced

Ranked by how much they should concern a holder

Demand & growth deceleration

High

Q2 revenue -22.7% YoY despite 41% H1 growth. Suggests demand cliff in H2. Market may be saturating or competitors gaining traction.

Working capital strain; inventory overhang

High

Inventory days doubled to 120+ from prior 60–65. Funded by debt ('increasing debt for WC requirements'). If sales don't accelerate, cash conversion will deteriorate further.

Refund/return cost inflation; fulfillment friction

High

Return & replacement costs spiked to INR1.7Cr (10x prior run-rate). Attributed to operational backlog (INR35–40L unfulfilled refunds). Flags product quality or fulfillment delays.

Margin pressure; Robu 2.0 unproven

Medium

Gross margin flat despite Robu 2.0 focus. Robu 2.0 <2% revenue, immaterial to margin profile. Higher corporate customer AOV reduces per-unit overhead but doesn't boost gross margin. Long-term margin expansion thesis unproven.

Vague guidance; reduced accountability

Medium

Management explicitly refusing to quantify guidance. MD: 'We have decided not to go in that direction, just to keep on putting some numbers to it.' Signals lower conviction or willingness to be held accountable for commitments.

Management

Score 5/10. Defensive on metrics. Refuses to share revenue mix, growth targets, or margin roadmap. Justifies poor metrics with supply-chain excuses; doesn't own operational issues. H1 delivered 41% growth; Q2 missed YoY by 22.7%. Inventory buildup uncontrolled (60→120 days). Refund backlog (INR35–40L) signals operational missteps. PAT margin stable but not improving.

What to watch next
  • 1 · Q3 FY27

    Inventory normalization; refund backlog clearance target

  • 2 · H2 FY27

    Robu 2.0 product SKU scaling & revenue contribution disclosure

  • 3 · FY28

    Gross margin expansion via proprietary products & tech (if Robu 2.0 gains traction)

Long-term electronics tailwind is credible, but near-term execution is faltering and management is unwilling to commit to specific guidance.

Informational and educational content only. Not investment advice.